Baxter International (NYSE: BAX) experienced a significant decline in its stock price, falling nearly 15% after reporting a mixed third quarter that missed analyst profitability expectations. The company announced a 5% year-over-year increase in total sales, reaching $2.84 billion, but its net income, not in accordance with GAAP, dropped 14% to $355 million, equating to $0.69 per share. This disappointing performance has raised concerns among investors.
